155 related articles for article (PubMed ID: 28213771)
21. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
Kim J; Kim H; Park SB
J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802
[TBL] [Abstract][Full Text] [Related]
22. Identification of Novel Human Breast Carcinoma (MDA-MB-231) Cell Growth Modulators from a Carbohydrate-Based Diversity Oriented Synthesis Library.
Lenci E; Innocenti R; Biagioni A; Menchi G; Bianchini F; Trabocchi A
Molecules; 2016 Oct; 21(10):. PubMed ID: 27775632
[TBL] [Abstract][Full Text] [Related]
23. Concise syntheses of 7-anilino-indoline-N-benzenesulfonamides as antimitotic and vascular disrupting agents.
Mehndiratta S; Chiang YF; Lai MJ; Lee HY; Chen MC; Kuo CC; Chang CY; Chang JY; Liou JP
Bioorg Med Chem; 2014 Sep; 22(17):4917-23. PubMed ID: 25059503
[TBL] [Abstract][Full Text] [Related]
24. Improving both aqueous solubility and anti-cancer activity by assessing progressive lead optimization libraries.
Liu Y; Li F; Wu L; Wang W; Zhu H; Zhang Q; Zhou H; Yan B
Bioorg Med Chem Lett; 2015 May; 25(9):1971-5. PubMed ID: 25827524
[TBL] [Abstract][Full Text] [Related]
25. Integrating virtual screening and biochemical experimental approach to identify potential anti-cancer agents from drug databank.
Deka SJ; Roy A; Manna D; Trivedi V
J Bioinform Comput Biol; 2018 Jun; 16(3):1850002. PubMed ID: 29566637
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of spiro[cyclopropane-1,3'-indolin]-2'-ones as potential anticancer agents.
Reddy CN; Nayak VL; Mani GS; Kapure JS; Adiyala PR; Maurya RA; Kamal A
Bioorg Med Chem Lett; 2015 Oct; 25(20):4580-6. PubMed ID: 26330077
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis of phenstatin/isocombretastatin-oxindole conjugates as antimitotic agents.
Kumar GB; Nayak VL; Sayeed IB; Reddy VS; Shaik AB; Mahesh R; Baig MF; Shareef MA; Ravikumar A; Kamal A
Bioorg Med Chem; 2016 Apr; 24(8):1729-40. PubMed ID: 26970659
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays.
Guo Z; Cheng Z; Wang J; Liu W; Peng H; Wang Y; Rao AVS; Li RJ; Ying X; Korangath P; Liberti MV; Li Y; Xie Y; Hong SY; Schiene-Fischer C; Fischer G; Locasale JW; Sukumar S; Zhu H; Liu JO
Angew Chem Int Ed Engl; 2019 Nov; 58(48):17158-17162. PubMed ID: 31591797
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of HSPA5 inhibitors: from peptide to small molecule inhibitors.
Huang M; Li Z; Li D; Walker S; Greenan C; Kennedy R
Bioorg Med Chem Lett; 2013 May; 23(10):3044-50. PubMed ID: 23562057
[TBL] [Abstract][Full Text] [Related]
30. Investigation of anti-tumor mechanisms of K2154: characterization of tubulin isotypes, mitotic arrest and apoptotic machinery.
Lu PH; Kung FL; Kuo SC; Chueh SC; Guh JH
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):223-33. PubMed ID: 17102938
[TBL] [Abstract][Full Text] [Related]
31. Water-soluble platinum phthalocyanines as potential antitumor agents.
Bologna G; Lanuti P; D'Ambrosio P; Tonucci L; Pierdomenico L; D'Emilio C; Celli N; Marchisio M; d'Alessandro N; Santavenere E; Bressan M; Miscia S
Biometals; 2014 Jun; 27(3):575-89. PubMed ID: 24699848
[TBL] [Abstract][Full Text] [Related]
32. Discovery of Small Molecules for Repressing Cap-Independent Translation of Human Vascular Endothelial Growth Factor (hVEGF) as Novel Antitumor Agents.
Wang SK; Wu Y; Wang XQ; Kuang GT; Zhang Q; Lin SL; Liu HY; Tan JH; Huang ZS; Ou TM
J Med Chem; 2017 Jul; 60(13):5306-5319. PubMed ID: 28530833
[TBL] [Abstract][Full Text] [Related]
33. Design and optimization of hybrid of 2,4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents.
Zhou W; Huang A; Zhang Y; Lin Q; Guo W; You Z; Yi Z; Liu M; Chen Y
Eur J Med Chem; 2015; 96():269-80. PubMed ID: 25899332
[TBL] [Abstract][Full Text] [Related]
34. Small-molecule intramimics of formin autoinhibition: a new strategy to target the cytoskeletal remodeling machinery in cancer cells.
Lash LL; Wallar BJ; Turner JD; Vroegop SM; Kilkuskie RE; Kitchen-Goosen SM; Xu HE; Alberts AS
Cancer Res; 2013 Nov; 73(22):6793-803. PubMed ID: 24242070
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of novel anti-proliferative pyrroloazepinone and indoloazepinone oximes derived from the marine natural product hymenialdisine.
White AW; Carpenter N; Lottin JR; McClelland RA; Nicholson RI
Eur J Med Chem; 2012 Oct; 56():246-53. PubMed ID: 22995819
[TBL] [Abstract][Full Text] [Related]
36. Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction.
Wang L; Li L; Zhou ZH; Jiang ZY; You QD; Xu XL
Eur J Med Chem; 2017 Aug; 136():63-73. PubMed ID: 28482218
[TBL] [Abstract][Full Text] [Related]
37. Rational Design of Small Molecules Targeting Oncogenic Noncoding RNAs from Sequence.
Disney MD; Angelbello AJ
Acc Chem Res; 2016 Dec; 49(12):2698-2704. PubMed ID: 27993012
[TBL] [Abstract][Full Text] [Related]
38. Spirooxindole-derived morpholine-fused-1,2,3-triazoles: Design, synthesis, cytotoxicity and apoptosis inducing studies.
Senwar KR; Sharma P; Reddy TS; Jeengar MK; Nayak VL; Naidu VG; Kamal A; Shankaraiah N
Eur J Med Chem; 2015 Sep; 102():413-24. PubMed ID: 26301558
[TBL] [Abstract][Full Text] [Related]
39. Dual targeting of tumour cells and host endothelial cells by novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines.
Nathwani SM; Butler S; Meegan MJ; Campiani G; Lawler M; Williams DC; Zisterer DM
Cancer Chemother Pharmacol; 2010 Jan; 65(2):289-300. PubMed ID: 19479253
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of substituted benzimidazolyl curcumin mimics and their anticancer activity.
Woo HB; Eom YW; Park KS; Ham J; Ahn CM; Lee S
Bioorg Med Chem Lett; 2012 Jan; 22(2):933-6. PubMed ID: 22222040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
